PDB Short entry for 2PZE HEADER HYDROLASE 17-MAY-07 2PZE TITLE MINIMAL HUMAN CFTR FIRST NUCLEOTIDE BINDING DOMAIN AS A HEAD-TO-TAIL TITLE 2 DIMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CFTR NBD1 387-646(DEL405-436); COMPND 5 SYNONYM: CFTR, CAMP- DEPENDENT CHLORIDE CHANNEL, ATP-BINDING CASSETTE COMPND 6 TRANSPORTER SUB- FAMILY C MEMBER 7; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CFTR, ABCC7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) CODON+RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: MODIFIED PET26B KEYWDS NBD, ABC TRANSPORTER, CFTR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.ATWELL,K.CONNERS,S.EMTAGE,T.GHEYI,N.R.GLENN,J.HENDLE,H.A.LEWIS, AUTHOR 2 F.LU,L.A.RODGERS,R.ROMERO,J.M.SAUDER,D.SMITH,H.TIEN,S.R.WASSERMAN, AUTHOR 3 X.ZHAO REVDAT 10 30-AUG-23 2PZE 1 REMARK SEQADV LINK REVDAT 9 14-NOV-18 2PZE 1 AUTHOR REVDAT 8 18-OCT-17 2PZE 1 REMARK REVDAT 7 16-AUG-17 2PZE 1 SOURCE REMARK REVDAT 6 30-JUN-10 2PZE 1 JRNL REVDAT 5 24-FEB-09 2PZE 1 VERSN REVDAT 4 30-SEP-08 2PZE 1 REVDAT 3 26-AUG-08 2PZE 1 JRNL REVDAT 2 05-AUG-08 2PZE 1 REMARK REVDAT 1 09-OCT-07 2PZE 0 JRNL AUTH S.ATWELL,C.G.BROUILLETTE,K.CONNERS,S.EMTAGE,T.GHEYI, JRNL AUTH 2 W.B.GUGGINO,J.HENDLE,J.F.HUNT,H.A.LEWIS,F.LU, JRNL AUTH 3 I.I.PROTASEVICH,L.A.RODGERS,R.ROMERO,S.R.WASSERMAN, JRNL AUTH 4 P.C.WEBER,D.WETMORE,F.F.ZHANG,X.ZHAO JRNL TITL STRUCTURES OF A MINIMAL HUMAN CFTR FIRST NUCLEOTIDE-BINDING JRNL TITL 2 DOMAIN AS A MONOMER, HEAD-TO-TAIL HOMODIMER, AND PATHOGENIC JRNL TITL 3 MUTANT. JRNL REF PROTEIN ENG.DES.SEL. V. 23 375 2010 JRNL REFN ISSN 1741-0126 JRNL PMID 20150177 JRNL DOI 10.1093/PROTEIN/GZQ004 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.ATWELL,K.CONNERS,S.EMTAGE,T.GHEYI,H.LEWIS,F.LU,R.ROMERO, REMARK 1 AUTH 2 X.ZHAO REMARK 1 TITL STRUCTURE OF THE HUMAN CFTR NBD1 DOMAIN AS A HOMODIMER: REMARK 1 TITL 2 INSIGHTS AND APPLICATIONS REMARK 1 REF PEDIATR.PULMONOL.SUPPL. V. 30 100 2007 REMARK 1 REFN ISSN 1054-187X REMARK 1 PMID 17729305 REMARK 1 DOI 10.1002/PPUL.20699 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 47005 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2405 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3342 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 194 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.82500 REMARK 3 B22 (A**2) : -0.18700 REMARK 3 B33 (A**2) : -0.63900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PZE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042955. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9796 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47121 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 22.094 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : 0.08600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.74900 REMARK 200 R SYM FOR SHELL (I) : 0.74900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1XMI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: 9.5MG/ML NBD1, 0.15M NACL, REMARK 280 0.01M METHIONINE, 0.01M HEPES PH 7.5, 10% GLYCEROL, 0.001M TCEP, REMARK 280 0.002M ATP; WELL: 0.1M HEPES PH 7.5, 25% PEG 6K; CRYO: 25% DMSO, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 281K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.40150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.70950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.38950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.70950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.40150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.38950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 637 REMARK 465 PRO A 638 REMARK 465 GLY A 646 REMARK 465 SER B 386 REMARK 465 LEU B 387 REMARK 465 THR B 388 REMARK 465 PHE B 640 REMARK 465 SER B 641 REMARK 465 SER B 642 REMARK 465 LYS B 643 REMARK 465 LEU B 644 REMARK 465 MET B 645 REMARK 465 GLY B 646 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 389 OG1 CG2 REMARK 470 GLU A 395 CG CD OE1 OE2 REMARK 470 GLU A 402 CG CD OE1 OE2 REMARK 470 GLU A 403 CG CD OE1 OE2 REMARK 470 LYS A 442 CD CE NZ REMARK 470 LYS A 447 NZ REMARK 470 GLU A 479 CG CD OE1 OE2 REMARK 470 LYS A 481 CG CD CE NZ REMARK 470 LYS A 483 CG CD CE NZ REMARK 470 PHE A 494 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 522 CD CE NZ REMARK 470 GLU A 528 CG CD OE1 OE2 REMARK 470 LYS A 532 CG CD CE NZ REMARK 470 PHE A 533 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 535 CG CD OE1 OE2 REMARK 470 LEU A 581 CG CD1 CD2 REMARK 470 LYS A 584 CD CE NZ REMARK 470 GLU A 608 CG CD OE1 OE2 REMARK 470 LYS A 612 CD CE NZ REMARK 470 GLN A 634 CG CD OE1 NE2 REMARK 470 ASN A 635 CG OD1 ND2 REMARK 470 LEU A 636 CG CD1 CD2 REMARK 470 LYS A 643 CD CE NZ REMARK 470 THR B 389 OG1 CG2 REMARK 470 GLU B 402 CG CD OE1 OE2 REMARK 470 GLU B 403 CG CD OE1 OE2 REMARK 470 GLU B 479 CG CD OE1 OE2 REMARK 470 LYS B 483 CD CE NZ REMARK 470 LYS B 532 CG CD CE NZ REMARK 470 LYS B 536 CD CE NZ REMARK 470 GLU B 543 CG CD OE1 OE2 REMARK 470 ILE B 546 CG1 CG2 CD1 REMARK 470 LYS B 584 CD CE NZ REMARK 470 GLU B 585 CD OE1 OE2 REMARK 470 LYS B 593 CD CE NZ REMARK 470 MET B 607 CG SD CE REMARK 470 GLU B 608 CG CD OE1 OE2 REMARK 470 LYS B 612 CD CE NZ REMARK 470 GLN B 637 CD OE1 NE2 REMARK 470 ASP B 639 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 403 84.37 -57.77 REMARK 500 LYS A 536 -127.60 43.06 REMARK 500 CYS A 590 -68.36 -92.84 REMARK 500 LYS A 593 -68.70 -105.92 REMARK 500 GLU B 403 -56.07 -24.20 REMARK 500 LYS B 536 -127.23 45.04 REMARK 500 CYS B 590 -65.87 -94.98 REMARK 500 LYS B 593 -65.97 -108.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLN B 637 PRO B 638 33.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1XMI RELATED DB: PDB REMARK 900 HUMAN CFTR NBD1 389-678(F429S,F508A,H667R) REMARK 900 RELATED ID: 1XMJ RELATED DB: PDB REMARK 900 HUMAN CFTR NBD1 389-678(F409L,F429S,F433L,DEL508,G550E,R553Q,R555K, REMARK 900 H667R) REMARK 900 RELATED ID: 2BB0 RELATED DB: PDB REMARK 900 HUMAN CFTR NBD1 389-678(F409L,F429S,F433L,G550E,R553Q,R555K,H667R) REMARK 900 RELATED ID: 2BBS RELATED DB: PDB REMARK 900 HUMAN CFTR NBD1 389-678(F429S,F494N,DEL508,Q637R) REMARK 900 RELATED ID: 2BBT RELATED DB: PDB REMARK 900 HUMAN CFTR NBD1 389-678(F494N,DEL508,Q637R) REMARK 900 RELATED ID: 1R0Z RELATED DB: PDB REMARK 900 MOUSE CFTR NBD1 389-673 REMARK 900 RELATED ID: 1R10 RELATED DB: PDB REMARK 900 MOUSE CFTR NBD1 389-673 REMARK 900 RELATED ID: 2IXE RELATED DB: PDB REMARK 900 HOMODIMER OF HUMAN TAP1 NBD(D645N) WITH ATP REMARK 900 RELATED ID: 1L2T RELATED DB: PDB REMARK 900 HOMODIMER OF METHANOCOCCUS JANNASCHII MJ0796(E171Q) REMARK 900 RELATED ID: 1Q12 RELATED DB: PDB REMARK 900 HOMODIMER OF E. COLI MALK REMARK 900 RELATED ID: 1XEF RELATED DB: PDB REMARK 900 HOMODIMER OF E. COLI HLYB NBD 467-707(H662A) REMARK 900 RELATED ID: 2HYD RELATED DB: PDB REMARK 900 HOMODIMER OF S. AUREUS ABC TRANSPORTER SAV1866 REMARK 900 RELATED ID: 2PZF RELATED DB: PDB REMARK 900 HUMAN NBD1 387-646(DEL 405-436, DEL 508) REMARK 900 RELATED ID: 2PZG RELATED DB: PDB REMARK 900 HUMAN NBD1 375-646(DEL 405-436) DBREF 2PZE A 387 404 UNP P13569 CFTR_HUMAN 387 404 DBREF 2PZE A 437 646 UNP P13569 CFTR_HUMAN 437 646 DBREF 2PZE B 387 404 UNP P13569 CFTR_HUMAN 387 404 DBREF 2PZE B 437 646 UNP P13569 CFTR_HUMAN 437 646 SEQADV 2PZE SER A 386 UNP P13569 EXPRESSION TAG SEQADV 2PZE SER B 386 UNP P13569 EXPRESSION TAG SEQADV 2PZE MET A 470 UNP P13569 VAL 470 VARIANT SEQADV 2PZE MET B 470 UNP P13569 VAL 470 VARIANT SEQRES 1 A 229 SER LEU THR THR THR GLU VAL VAL MET GLU ASN VAL THR SEQRES 2 A 229 ALA PHE TRP GLU GLU GLY GLY THR PRO VAL LEU LYS ASP SEQRES 3 A 229 ILE ASN PHE LYS ILE GLU ARG GLY GLN LEU LEU ALA VAL SEQRES 4 A 229 ALA GLY SER THR GLY ALA GLY LYS THR SER LEU LEU MET SEQRES 5 A 229 MET ILE MET GLY GLU LEU GLU PRO SER GLU GLY LYS ILE SEQRES 6 A 229 LYS HIS SER GLY ARG ILE SER PHE CYS SER GLN PHE SER SEQRES 7 A 229 TRP ILE MET PRO GLY THR ILE LYS GLU ASN ILE ILE PHE SEQRES 8 A 229 GLY VAL SER TYR ASP GLU TYR ARG TYR ARG SER VAL ILE SEQRES 9 A 229 LYS ALA CYS GLN LEU GLU GLU ASP ILE SER LYS PHE ALA SEQRES 10 A 229 GLU LYS ASP ASN ILE VAL LEU GLY GLU GLY GLY ILE THR SEQRES 11 A 229 LEU SER GLY GLY GLN ARG ALA ARG ILE SER LEU ALA ARG SEQRES 12 A 229 ALA VAL TYR LYS ASP ALA ASP LEU TYR LEU LEU ASP SER SEQRES 13 A 229 PRO PHE GLY TYR LEU ASP VAL LEU THR GLU LYS GLU ILE SEQRES 14 A 229 PHE GLU SER CYS VAL CYS LYS LEU MET ALA ASN LYS THR SEQRES 15 A 229 ARG ILE LEU VAL THR SER LYS MET GLU HIS LEU LYS LYS SEQRES 16 A 229 ALA ASP LYS ILE LEU ILE LEU HIS GLU GLY SER SER TYR SEQRES 17 A 229 PHE TYR GLY THR PHE SER GLU LEU GLN ASN LEU GLN PRO SEQRES 18 A 229 ASP PHE SER SER LYS LEU MET GLY SEQRES 1 B 229 SER LEU THR THR THR GLU VAL VAL MET GLU ASN VAL THR SEQRES 2 B 229 ALA PHE TRP GLU GLU GLY GLY THR PRO VAL LEU LYS ASP SEQRES 3 B 229 ILE ASN PHE LYS ILE GLU ARG GLY GLN LEU LEU ALA VAL SEQRES 4 B 229 ALA GLY SER THR GLY ALA GLY LYS THR SER LEU LEU MET SEQRES 5 B 229 MET ILE MET GLY GLU LEU GLU PRO SER GLU GLY LYS ILE SEQRES 6 B 229 LYS HIS SER GLY ARG ILE SER PHE CYS SER GLN PHE SER SEQRES 7 B 229 TRP ILE MET PRO GLY THR ILE LYS GLU ASN ILE ILE PHE SEQRES 8 B 229 GLY VAL SER TYR ASP GLU TYR ARG TYR ARG SER VAL ILE SEQRES 9 B 229 LYS ALA CYS GLN LEU GLU GLU ASP ILE SER LYS PHE ALA SEQRES 10 B 229 GLU LYS ASP ASN ILE VAL LEU GLY GLU GLY GLY ILE THR SEQRES 11 B 229 LEU SER GLY GLY GLN ARG ALA ARG ILE SER LEU ALA ARG SEQRES 12 B 229 ALA VAL TYR LYS ASP ALA ASP LEU TYR LEU LEU ASP SER SEQRES 13 B 229 PRO PHE GLY TYR LEU ASP VAL LEU THR GLU LYS GLU ILE SEQRES 14 B 229 PHE GLU SER CYS VAL CYS LYS LEU MET ALA ASN LYS THR SEQRES 15 B 229 ARG ILE LEU VAL THR SER LYS MET GLU HIS LEU LYS LYS SEQRES 16 B 229 ALA ASP LYS ILE LEU ILE LEU HIS GLU GLY SER SER TYR SEQRES 17 B 229 PHE TYR GLY THR PHE SER GLU LEU GLN ASN LEU GLN PRO SEQRES 18 B 229 ASP PHE SER SER LYS LEU MET GLY HET MG A 3 1 HET ATP A 1 31 HET MG B 4 1 HET ATP B 2 31 HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 3 MG 2(MG 2+) FORMUL 4 ATP 2(C10 H16 N5 O13 P3) FORMUL 7 HOH *194(H2 O) HELIX 1 1 GLY A 463 MET A 472 1 10 HELIX 2 2 THR A 501 PHE A 508 1 8 HELIX 3 3 ASP A 513 CYS A 524 1 12 HELIX 4 4 LEU A 526 SER A 531 1 6 HELIX 5 5 GLU A 535 ILE A 539 5 5 HELIX 6 6 SER A 549 LYS A 564 1 16 HELIX 7 7 ASP A 579 CYS A 590 1 12 HELIX 8 8 LYS A 606 ALA A 613 1 8 HELIX 9 9 THR A 629 ASN A 635 1 7 HELIX 10 10 ASP A 639 MET A 645 1 7 HELIX 11 11 GLY B 463 MET B 472 1 10 HELIX 12 12 ILE B 502 PHE B 508 1 7 HELIX 13 13 ASP B 513 CYS B 524 1 12 HELIX 14 14 LEU B 526 SER B 531 1 6 HELIX 15 15 GLU B 535 ASN B 538 5 4 HELIX 16 16 GLY B 542 ILE B 546 5 5 HELIX 17 17 SER B 549 LYS B 564 1 16 HELIX 18 18 ASP B 579 CYS B 590 1 12 HELIX 19 19 LYS B 606 LYS B 611 1 6 HELIX 20 20 THR B 629 ASN B 635 1 7 SHEET 1 A 3 LEU A 441 GLU A 449 0 SHEET 2 A 3 THR A 390 ALA A 399 -1 N GLU A 391 O ILE A 448 SHEET 3 A 3 GLU A 479 HIS A 484 -1 O LYS A 483 N VAL A 393 SHEET 1 B 6 ILE A 488 CYS A 491 0 SHEET 2 B 6 LEU A 568 ASP A 572 1 O LEU A 570 N SER A 489 SHEET 3 B 6 THR A 599 VAL A 603 1 O ILE A 601 N LEU A 571 SHEET 4 B 6 LEU A 453 ALA A 457 1 N VAL A 456 O LEU A 602 SHEET 5 B 6 LYS A 615 HIS A 620 1 O LEU A 617 N ALA A 455 SHEET 6 B 6 SER A 623 GLY A 628 -1 O TYR A 625 N ILE A 618 SHEET 1 C 3 LEU B 441 GLU B 449 0 SHEET 2 C 3 THR B 390 ALA B 399 -1 N MET B 394 O PHE B 446 SHEET 3 C 3 GLU B 479 HIS B 484 -1 O LYS B 483 N VAL B 393 SHEET 1 D 6 ILE B 488 CYS B 491 0 SHEET 2 D 6 LEU B 568 ASP B 572 1 O LEU B 570 N CYS B 491 SHEET 3 D 6 ARG B 600 VAL B 603 1 O ILE B 601 N TYR B 569 SHEET 4 D 6 LEU B 453 ALA B 457 1 N LEU B 454 O ARG B 600 SHEET 5 D 6 LYS B 615 HIS B 620 1 O LEU B 619 N ALA B 457 SHEET 6 D 6 SER B 623 GLY B 628 -1 O GLY B 628 N ILE B 616 SHEET 1 E 2 GLY B 500 THR B 501 0 SHEET 2 E 2 VAL B 540 LEU B 541 -1 O LEU B 541 N GLY B 500 LINK C GLY A 404 N GLY A 437 1555 1555 1.33 LINK C GLY B 404 N GLY B 437 1555 1555 1.34 SITE 1 AC1 5 ATP A 1 THR A 465 GLN A 493 HOH A 647 SITE 2 AC1 5 HOH A 648 SITE 1 AC2 5 ATP B 2 THR B 465 GLN B 493 HOH B 647 SITE 2 AC2 5 HOH B 648 SITE 1 AC3 23 MG A 3 TRP A 401 VAL A 440 THR A 460 SITE 2 AC3 23 GLY A 461 ALA A 462 GLY A 463 LYS A 464 SITE 3 AC3 23 THR A 465 SER A 466 GLN A 493 HOH A 647 SITE 4 AC3 23 HOH A 648 HOH A 661 HOH A 681 HOH A 693 SITE 5 AC3 23 HOH A 706 PHE B 533 THR B 547 SER B 549 SITE 6 AC3 23 GLY B 550 GLY B 551 GLN B 552 SITE 1 AC4 20 THR A 547 SER A 549 GLY A 550 GLY A 551 SITE 2 AC4 20 GLN A 552 MG B 4 TRP B 401 VAL B 440 SITE 3 AC4 20 THR B 460 GLY B 461 ALA B 462 GLY B 463 SITE 4 AC4 20 LYS B 464 THR B 465 SER B 466 GLN B 493 SITE 5 AC4 20 HOH B 647 HOH B 648 HOH B 649 HOH B 686 CRYST1 42.803 92.779 107.419 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023363 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010778 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009309 0.00000